Assessment of Serum Lipid Profiles and High-sensitivity C-reactive Protein Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study

被引:9
作者
Dessie, Gashaw [1 ]
Tadesse, Yewondwossen [2 ]
Demelash, Birhanu [2 ]
Genet, Solomon [3 ]
机构
[1] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia
[2] Addis Ababa Univ, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia
[3] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Biochem, Addis Ababa, Ethiopia
来源
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS | 2020年 / 12卷
关键词
rheumatoid arthritis; lipid profiles; high-sensitivity C-reactive protein; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; INFLAMMATION; MARKER;
D O I
10.2147/OARRR.S264466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by severe joint pain, swelling, damage, and disability which leads to joint destruction and loss of function. The complication of RA is associated with cardiovascular diseases, particularly due to systemic inflammation and dyslipidemia. The purpose of this study was to assess the development of atherosclerosis, which acts as a major risk factor for cardiovascular complications in RA patients. Methods: A hospital-based cross-sectional study was conducted at the Rheumatology Clinic of Tikur Anbessa Specialized Hospital. The study made a comparison of risk factors (dyslipidemia and inflammatory status) between individuals having RA as a case group and apparently healthy individuals as a control group. Simple descriptive statistics, one-way ANOVA, independent sample t-test and multivariate analysis were utilized for statistical analysis. p-value of <0.05 at the 95% confidence level was considered as statistically significant. Results: The result of this study demonstrated that there was a significant elevation of mean +/- SD of TC, TC/HDL, LDL/HDL, and lowered value of HDL-C was seen among RA patients than controls (P-value <0.05). The mean +/- SD of inflammatory marker, high-sensitivity C-reactive protein (hsCRP), was significantly higher among RA patients compared to controls (P<0.05). HDL-C had a significant negative correlation with a hsCRP whereas TC/HDL-C and LDL/HDL-C had a significant positive correlation with hsCRP (P<0.05). Conclusion: In this study, RA patients had lipid abnormalities and elevated systemic inflammation than controls. An increase in hsCRP and dyslipidemia status among RA patients indicates the possible development of an atherosclerotic event. Therefore, assessment of lipid profiles and hsCRP in early RA patients may be helpful to assess the possible development of cardiovascular complications.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 37 条
[1]   Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis [J].
Aletaha, Daniel ;
Maa, Jen-Fue ;
Chen, Su ;
Park, Sung-Hwan ;
Nicholls, Dave ;
Florentinus, Stefan ;
Furtner, Daniel ;
Smolen, Josef S. .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (12) :1609-1615
[2]  
Ansari SK, RAISED LIPID PROFILE
[3]   Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis [J].
Baumer, Yvonne ;
McCurdy, Sara ;
Weatherby, Tina M. ;
Mehta, Nehal N. ;
Halbherr, Stefan ;
Halbherr, Pascal ;
Yamazaki, Noboru ;
Boisvert, William A. .
NATURE COMMUNICATIONS, 2017, 8
[4]   Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study [J].
Bengtsson, C ;
Nordmark, B ;
Klareskog, L ;
Lundberg, I ;
Alfredsson, L .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1588-1594
[5]   Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis [J].
Chang, Pi-Yueh ;
Yang, Cheng-Tao ;
Cheng, Ching-Hui ;
Yu, Kuang-Hui .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) :880-886
[6]   Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment [J].
Choy, Ernest ;
Ganeshalingam, Kandeepan ;
Semb, Anne Grete ;
Szekanecz, Zoltan ;
Nurmohamed, Michael .
RHEUMATOLOGY, 2014, 53 (12) :2143-2154
[7]   The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study [J].
Cross, Marita ;
Smith, Emma ;
Hoy, Damian ;
Carmona, Loreto ;
Wolfe, Frederick ;
Vos, Theo ;
Williams, Benjamin ;
Gabriel, Sherine ;
Lassere, Marissa ;
Johns, Nicole ;
Buchbinder, Rachelle ;
Woolf, Anthony ;
March, Lyn .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1316-1322
[8]   Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM [J].
Fautrel, Bruno ;
Kirkham, Bruce ;
Pope, Janet E. ;
Takeuchi, Tsutomu ;
Gaich, Carol ;
Quebe, Amanda ;
Zhu, Baojin ;
de la Torre, Inmaculada ;
De Leonardis, Francesco ;
Taylor, Peter C. .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
[9]   Redox signalling and the inflammatory response in rheumatoid arthritis [J].
Filippin, L. I. ;
Vercelino, R. ;
Marroni, N. P. ;
Xavier, R. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (03) :415-422
[10]   C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis [J].
Galarraga, B. ;
Khan, F. ;
Kumar, P. ;
Pullar, T. ;
Belch, J. J. F. .
RHEUMATOLOGY, 2008, 47 (12) :1780-1784